Skip to content

NVP ASSOCIATES, LLC

Follow

13F filer, CIK 1545692, MENLO PARK, CA

NVP ASSOCIATES, LLC reported $281,952,348 across 6 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.

Accepted , ingested 13F-HR 0001545692-26-000013

Period
2026-09-30
Reported value
$282M
Holdings
6
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
OMDAexited-2,531,000-$55.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001545692-26-000013, largest first. % of portfolio is the value over $281,952,348, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,136,335 shares; 2025Q1: 2,136,335 shares; 2025Q2: 2,136,335 shares; 2025Q3: 2,136,335 shares; 2025Q4: 2,136,335 shares; 2026Q1: 2,136,335 shares; 2026Q2: 2,136,335 shares; 2026Q3: 2,136,335 shares 2,136,335$125M44.42%0Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,268,404 shares; 2026Q3: 2,268,404 shares 2,268,404$64.6M22.92%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,838,482 shares; 2025Q1: 1,838,482 shares; 2025Q2: 1,838,482 shares; 2025Q3: 1,838,482 shares; 2025Q4: 1,838,482 shares; 2026Q1: 1,838,482 shares; 2026Q2: 1,838,482 shares; 2026Q3: 1,838,482 shares 1,838,482$49.6M17.59%0Timeline
SNOWSNOWFLAKE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 114,786 shares; 2026Q3: 114,786 shares 114,786$39M13.82%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,943,522 shares; 2025Q1: 3,225,097 shares; 2025Q2: 3,225,097 shares; 2025Q3: 3,225,097 shares; 2025Q4: 3,225,097 shares; 2026Q1: 3,225,097 shares; 2026Q2: 3,225,097 shares; 2026Q3: 3,225,097 shares 3,225,097$3.42M1.21%0Timeline
ONDSONDAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,602 shares; 2026Q3: 15,602 shares 15,602$114K0.04%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
OMDAOMADA HEALTH INC2,531,000$55.6Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001545692-26-000013 base2026-11-13